Q/C Technologies, Inc. Proceeds from License Fees Received
Q/C Technologies, Inc. (QCLS) reported Proceeds from License Fees Received of $1.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLicenseFeesReceived · last filed 2015-05-14
- Q/C Technologies, Inc. proceeds from license fees received for the quarter ending 2014-03-31 was $450.00K.
- Q/C Technologies, Inc. proceeds from license fees received for fiscal 2014 was $1.00M, a 0.00% change from fiscal 2013.
- Q/C Technologies, Inc. proceeds from license fees received for fiscal 2013 was $1.00M.
| Period end | Proceeds from License Fees Received 0 month | Proceeds from License Fees Received 3 month | Proceeds from License Fees Received 12 month |
|---|---|---|---|
| 2014-12-31 | $1.00M 10-K · filed 2015-03-23 | ||
| 2014-03-31 | $450.00K 10-Q · filed 2014-05-14 | ||
| 2013-12-31 | $1.00M 10-K · filed 2015-03-23 | ||
| 2012-06-19 | $1.00M 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |